Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.
Financial Results:
Mankind Pharma Ltd reported Revenues for Q4FY25 of ₹3,079.00 Crores up from ₹2,422.00 Crore year on year, a rise of 27.13%.
Total Expenses for Q4FY25 of ₹2,818.00 Crores up from ₹1,945.00 Crores year on year, a rise of 44.88%.
Consolidated Net Profit of ₹425.00 Crores down 10.9% from ₹477.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹10.20, down 13.27% from ₹11.76 in the same quarter of the previous year.